Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxandrolone add-on to growth hormone and estrogen in girls with Turner syndrome
NL-OMON23518Active, not recruiting
- Sponsor
- Pfizer
- Start
- Jan 1992
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxandrolone, somatropin and esterified estrogens in Turner syndrome (TS) (3 arms), sponsored by Pfizer. Primary endpoint: Final height. Started Jan 1992; status: active, not recruiting.
02
Drugs
oxandrolonesomatropinesterified estrogens
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NL-OMON23518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23518.